This Article Full Text Full Text (PDF) All Versions of this Article: 42/1/39    most recent 01.HYP.0000074428.11168.EEv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sattar, N. Articles by Greer, I. A. Search for Related Content PubMed PubMed Citation Articles by Sattar, N. Articles by Greer, I. A. Related Collections Clinical Studies Other hypertension

(Hypertension. 2003;42:39.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Classic and Novel Risk Factor Parameters in Women With a History of Preeclampsia

Naveed Sattar; Jane Ramsay; Lynne Crawford; Helen Cheyne; Ian A. Greer

From the University Departments of Pathological Biochemistry (N.S., L.C.) and Obstetrics and Gynaecology (J.R., H.C., I.A.G.), Glasgow Royal Infirmary University NHS Trust, Glasgow, Scotland.

Correspondence to Prof Ian Greer, Department of Obstetrics and Gynaecology, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER UK. E-mail I.A.Greer{at}clinmed.gla.ac.uk

Epidemiological studies demonstrate a relation between preeclampsia (PE) and an increased risk of maternal coronary heart disease (CHD) in later life. However, there are few data available to explain any underlying mechanism. We recruited 40 primigravid women with a history of proteinuric PE delivering between 1975 and 1985 and 40 controls, matched as a group for time of index pregnancy, smoking, and current body mass index to assess classic (lipids, blood pressure) and novel (adhesion molecules, insulin, leptin) risk factor pathways. Women with a history of PE had higher diastolic blood pressure compared with controls (83 vs 76 mm Hg, P<0.05), but there were no significant differences in fasting lipoprotein concentrations (P>0.20). However, concentrations of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 (ICAM-1) in particular were higher in the PE group by 14% (P=0.038) and 44% (P=0.002), respectively. The cases also demonstrated a tendency toward higher fasting insulin (P=0.08) concentrations and had higher glycosylated hemoglobin levels (P=0.004). Leptin concentrations were not significantly elevated. Interestingly, significantly more of the women with history of PE were classified as menopausal (37.55% vs 17.5%, P=0.045). The differences in ICAM-1 concentration persisted (P=0.010) after adjustment for potential confounders, including hormonal use/menopausal status, antihypertensive or lipid-lowering therapy, and social class. We conclude that classic risk factors alone cannot fully explain the elevated CHD risk in women with a history of PE. Rather markedly elevated ICAM-1 concentrations and specific but subtle features of the metabolic syndrome (glucose, blood pressure) are likely to be involved.

Key Words: pregnancy • endothelium • insulin resistance • lipoproteins • coronary disease

This article has been cited by other articles:

				B. E. Vikse, L. M. Irgens, T. Leivestad, R. Skjaerven, and B. M. Iversen Preeclampsia and the Risk of End-Stage Renal Disease N. Engl. J. Med., August 21, 2008; 359(8): 800 - 809. [Abstract] [Full Text] [PDF]

				A. L. Berends, C. J.M. de Groot, E. J. Sijbrands, M. P.S. Sie, S. H. Benneheij, R. Pal, R. Heydanus, B. A. Oostra, C. M. van Duijn, and E. A.P. Steegers Shared Constitutional Risks for Maternal Vascular-Related Pregnancy Complications and Future Cardiovascular Disease Hypertension, April 1, 2008; 51(4): 1034 - 1041. [Abstract] [Full Text] [PDF]

				J. Girouard, Y. Giguere, J.-M. Moutquin, and J.-C. Forest Previous Hypertensive Disease of Pregnancy Is Associated With Alterations of Markers of Insulin Resistance Hypertension, May 1, 2007; 49(5): 1056 - 1062. [Abstract] [Full Text] [PDF]

				S. Sabour, A. Franx, A. Rutten, D. E. Grobbee, M. Prokop, M.-L. Bartelink, Y. T. van der Schouw, and M. L. Bots High Blood Pressure in Pregnancy and Coronary Calcification Hypertension, April 1, 2007; 49(4): 813 - 817. [Abstract] [Full Text] [PDF]

				J. Blaauw, M. G. van Pampus, J. J. Van Doormaal, M. R. Fokkema, V. Fidler, A. J. Smit, and J. G. Aarnoudse Increased intima-media thickness after early-onset preeclampsia. Obstet. Gynecol., June 1, 2006; 107(6): 1345 - 1351. [Abstract] [Full Text] [PDF]

				R. J. Kaaja and I. A. Greer Manifestations of Chronic Disease During Pregnancy JAMA, December 7, 2005; 294(21): 2751 - 2757. [Abstract] [Full Text] [PDF]

				J.-C. Forest, J. Girouard, J. Masse, J.-M. Moutquin, A. Kharfi, R. B. Ness, J. M. Roberts, and Y. Giguere Early Occurrence of Metabolic Syndrome After Hypertension in Pregnancy Obstet. Gynecol., June 1, 2005; 105(6): 1373 - 1380. [Abstract] [Full Text] [PDF]

				D. A Lawlor, S. M B Morton, D. Nitsch, and D. A Leon Association between childhood and adulthood socioeconomic position and pregnancy induced hypertension: results from the Aberdeen children of the 1950s cohort study J. Epidemiol. Community Health, January 1, 2005; 59(1): 49 - 55. [Abstract] [Full Text] [PDF]

				D. J. Freeman, F. McManus, E. A. Brown, L. Cherry, J. Norrie, J. E. Ramsay, P. Clark, I. D. Walker, N. Sattar, and I. A. Greer Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia Hypertension, November 1, 2004; 44(5): 708 - 714. [Abstract] [Full Text] [PDF]

				The Link Between Preeclampsia and Future Atherosclerosis Journal Watch Cardiology, October 17, 2003; 2003(1017): 6 - 6. [Full Text]

				The Link Between Preeclampsia and Future Atherosclerosis Journal Watch Women's Health, September 23, 2003; 2003(923): 1 - 1. [Full Text]